InvestorsHub Logo

Lemoncat

07/09/21 7:03 PM

#364835 RE: To infinity and beyond! #364785

What say you about yest assertion that great data woulda led to a trial halt? Bound to be the case.



That may or may not be true.

Trial failure <-----Lots of good outcomes-----> Trial-haltingly Good

Lot's of very profitable meat in the middle there. Remdesivir is probably 2 ticks from Trial failure and billed $2B/year.

We only need $200M/year to send us through $3/share.

Go IPIX!